TrialJAMA2023

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.

Hai-Qiang Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.